PubMed:33754144 / 0-192 JSON TXT

Annnotations TAB JSON ListView MergeView

Id	Subject	Object	Predicate	Lexical cue
T1	0-192	Sentence	denotes	Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial.
T1	0-192	Sentence	denotes	Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial.

Id	Subject	Object	Predicate	Lexical cue
T1	37-55	DP	denotes	COVID-19 pneumonia
T4	0-12	CI	denotes	Mavrilimumab

Id	Subject	Object	Predicate	Lexical cue
T5	0-12	CI	denotes	Mavrilimumab
T15	37-55	DP	denotes	COVID-19 pneumonia